This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Vision-Sciences To Discuss EndoSheath(R) Technology On "Taking Stock With Pimm Fox"

ORANGEBURG, N.Y., March 17, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, is pleased to announce that Cheryl Pegus, M.D., President of Caluent, Director and Strategic Advisor of Glytec, and the Lead Independent Director of Vision-Sciences, will appear on a segment of the Bloomberg News TV show "Taking Stock with Pimm Fox" on Wednesday, March 19, 2014 during the 5:00 – 6:00 PM EDT hour.

"We are thrilled that Dr. Pegus will have the opportunity to discuss Vision Sciences' innovative Endosheath technology on Taking Stock with Pimm Fox," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences. "Our technology has become even more relevant in light of the recent focus on hospital-acquired infections and the steps the healthcare industry needs to take to help prevent these infections from developing."

Vision-Sciences' patented and FDA-cleared EndoSheath technology is the only flexible endoscopic technology on the market with a sterile, single-use barrier which prevents direct contact with the patient and reduces the difficulties of providing a sterile, patient ready device. In 20 years and with over 5 million procedures performed with EndoSheath technology, Vision-Sciences has never received a report of patient-to-patient cross-contamination.

Segment Details:

Date: Wednesday, March 19, 2014

Time:  5:00 – 6:00 PM EDT

Outlet:   Bloomberg News TV "Taking Stock with Pimm Fox"

For more information call Mitch Kayden at 845-709-5607 or email at mkayden@onitdigital.com.

About Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath ® technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com .

Vision-Sciences owns the trademark Vision Sciences™ and the registered trademarks EndoSheath ®, EndoWipe ®, Slide-On ®, and The Vision System ®.

CONTACT: Mitch Kayden
         Sr. Media Strategist
         Onit Digital Marketing
         (845) 709-5607
         mkayden@onitdigital.com
         
         Keith J. C. Darragh
         VP, Finance
         Vision-Sciences, Inc.
         (845) 365-0600
         invest@visionsciences.com

company logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs